4.7 Article

Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic

期刊

CLINICAL INFECTIOUS DISEASES
卷 75, 期 SUPPL 1, 页码 S5-S10

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac301

关键词

COVID-19 vaccine; clinical trials; study design; pandemic preparedness

资金

  1. Sanofi
  2. Merck
  3. Pfizer
  4. Lilly
  5. Quidel

向作者/读者索取更多资源

This article reviews the importance of vaccine clinical trials in developing effective COVID-19 vaccines. It highlights the challenges of supply chain disruptions, infection control, study designs, and participant factors, as well as specific solutions to streamline the clinical trial process.
Vaccine clinical trials were essential to developing effective severe acute respiratory syndrome coronavirus 2 vaccines. The challenges of supply chain disruptions, infection control, study designs, and participant factors are reviewed, along with ways to streamline the clinical trial process. Vaccine clinical trials have been essential to developing effective severe acute respiratory syndrome coronavirus 2 vaccines. The challenges of supply chain disruptions, infection control, study designs, and participant factors that affect trial procedures are reviewed, with specific solutions to streamline the clinical trial process.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据